{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:21:16Z","timestamp":1762521676264},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/fbp.0000000000000030","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T12:35:20Z","timestamp":1392899720000},"page":"158-165","source":"Crossref","is-referenced-by-count":13,"title":["Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice"],"prefix":"10.1097","volume":"25","author":[{"given":"Nobue","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neures.2005.05.002","article-title":"Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.","volume":"52","author":"Askalany","year":"2005","journal-title":"Neurosci Res"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-3057(82)90478-6","article-title":"Dopaminergic properties of nomifensine.","volume":"17","author":"Gianutsos","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain.","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS drugs"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(91)91156-U","article-title":"Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.","volume":"546","author":"Hamamura","year":"1991","journal-title":"Brain Res"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review.","volume":"69","author":"Karila","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0361-9230(97)00093-2","article-title":"MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.","volume":"44","author":"Kim","year":"1997","journal-title":"Brain Res Bull"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroscience.2004.09.026","article-title":"Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum.","volume":"130","author":"Kitanaka","year":"2005","journal-title":"Neuroscience"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02245111","article-title":"Effects of repeated MK-801 on ambulation in mice and in sensitization following methamphetamine.","volume":"108","author":"Kuribara","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0006-8993(93)90135-A","article-title":"MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity.","volume":"625","author":"Layer","year":"1993","journal-title":"Brain Res"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pharmthera.2011.12.005","article-title":"Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential.","volume":"133","author":"Molderings","year":"2012","journal-title":"Pharmacol Ther"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(92)90642-K","article-title":"MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum.","volume":"136","author":"Muraki","year":"1992","journal-title":"Neurosci Lett"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(83)90006-7","article-title":"Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.","volume":"88","author":"Nishikawa","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1304.007","article-title":"Agmatine crosses the blood-brain barrier.","volume":"1009","author":"Piletz","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00404607","article-title":"Stereotyped activities produced by amphetamine in several animal species and man.","volume":"11","author":"Randrup","year":"1967","journal-title":"Psychopharmacologia"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/jpet.105.086173","article-title":"Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse.","volume":"314","author":"Roberts","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroscience.2012.05.015","article-title":"Agmatine selectively improves behavioural function in aged male Sprague-Dawley rats.","volume":"218","author":"Rushaidhi","year":"2012","journal-title":"Neuroscience"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior.","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R34-7-20210202","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.npp.1300929","article-title":"Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha2-adrenoceptors.","volume":"31","author":"Tahsili-Fahadan","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R35-7-20210202","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11064-006-9180-1","article-title":"Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice.","volume":"31","author":"Tatsuta","year":"2006","journal-title":"Neurochem Res"},{"key":"R36-7-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2007.03.019","article-title":"Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.","volume":"87","author":"Tatsuta","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"R37-7-20210202","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2012.01.037","article-title":"Agmatine attenuates methamphetamine-induced conditioned place preference in rats.","volume":"680","author":"Thorn","year":"2012","journal-title":"Eur J Pharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:00:36Z","timestamp":1620954036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201404000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000030","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}